Production Capabilities in US Nuclear Reactors for Medical Radioisotopes
PRODUCTION CAPABILITIES IN U. S. NUCLEAR REACTORS FOR MEDICAL RADIOISOTOPES S. Mirzadeh 76 (13.3o/o) A. P. Callahan ,-o, ]_,_ R.E. Schenter ,_,,e _o,,-[ F.F. (Russ) Knapp, Jr. le_w 18ew 74 (28.6%) 69,4d 112 114 LEFT IRIDIUM 191M DISTRIBUTION OF THIS DOCUMENT IS UNLIMITE_D reportMs been reproduceddirectly from the best available copy. Available to DOE and DOE contractors from the Office of Sc_ffic end Techni- cal Information,P.O. Box 62, Oak Ridge, TN 37831; prices available from (615) 576-8401, FTS 826-8401. Available to the pub_ from the National Technical Infornmtion Service, U.S. Departmentof Commerce, 5285 Port Royal lid., Springfield,VA 22161. TNa report was prepared as an account of work sponsored by an agency of the United States Government. Neither the United States Government nor any agency thereof, nor any of their employees, makes any warranty, exprm or klq:4lad, or assumes any legal liability or re_oonslbilltyfor the accuracy, com- pleteness, or usefulnessof any information,apparatus, product, or process dis- closed, or rel)resem that its use would not infringe privately owned rights. Reference herein to any specific commercial product: proce_, or service by trade name, trademark, manufacturer, or otherwise, does not necessarily consti- tute or knply its endorsement,r,mornnwndstion,or favoringby the United States Government or any agency thereof. The views and opinions of authors expressed herein do not necessarily state or reflect those of the United States L Government or any agency thereof. Cover The ORNL High Flux Reactor has the highest thermal neutron flux and is used to produce tungsten-188 which is the parent for a generator system providing carrier-free rhenium-188 for therapeutic applications.
[Show full text]